BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1062 related articles for article (PubMed ID: 25636967)

  • 1. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
    Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
    Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross regulation between mTOR signaling and O-GlcNAcylation.
    Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
    J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.
    Itkonen HM; Minner S; Guldvik IJ; Sandmann MJ; Tsourlakis MC; Berge V; Svindland A; Schlomm T; Mills IG
    Cancer Res; 2013 Aug; 73(16):5277-87. PubMed ID: 23720054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway.
    Ferrer CM; Lu TY; Bacigalupa ZA; Katsetos CD; Sinclair DA; Reginato MJ
    Oncogene; 2017 Jan; 36(4):559-569. PubMed ID: 27345396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.
    Itkonen HM; Urbanucci A; Martin SE; Khan A; Mathelier A; Thiede B; Walker S; Mills IG
    Theranostics; 2019; 9(8):2183-2197. PubMed ID: 31149037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-GlcNAc Transferase Regulates Cancer Stem-like Potential of Breast Cancer Cells.
    Akella NM; Le Minh G; Ciraku L; Mukherjee A; Bacigalupa ZA; Mukhopadhyay D; Sodi VL; Reginato MJ
    Mol Cancer Res; 2020 Apr; 18(4):585-598. PubMed ID: 31974291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells.
    Raab S; Gadault A; Very N; Decourcelle A; Baldini S; Schulz C; Mortuaire M; Lemaire Q; Hardivillé S; Dehennaut V; El Yazidi-Belkoura I; Vercoutter-Edouart AS; Panasyuk G; Lefebvre T
    Cell Mol Life Sci; 2021 Jul; 78(13):5397-5413. PubMed ID: 34046694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
    Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
    J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
    Goldberg H; Whiteside C; Fantus IG
    Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
    Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
    Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Zhang N; Chen X
    Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing β-linked N-acetylglucosamine transferase induces apoptosis in human gastric cancer cells through PUMA and caspase-3 pathways.
    Wen T; Hou K; Li Z; Li L; Yu H; Liu Y; Li Y; Yin Z
    Oncol Rep; 2015 Dec; 34(6):3140-6. PubMed ID: 26397041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented TME
    Moriwaki K; Asahi M
    Mol Cancer Res; 2017 Sep; 15(9):1287-1298. PubMed ID: 28536142
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
    Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
    BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway.
    Ferrer CM; Lynch TP; Sodi VL; Falcone JN; Schwab LP; Peacock DL; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cell; 2014 Jun; 54(5):820-31. PubMed ID: 24857547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy.
    Zhang X; Ma L; Qi J; Shan H; Yu W; Gu Y
    Mol Cell Biochem; 2015 Dec; 410(1-2):101-10. PubMed ID: 26318312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 54.